131 related articles for article (PubMed ID: 37478497)
1. Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum.
Schneck NA; Mehl JT; Kellie JF
J Am Soc Mass Spectrom; 2023 Sep; 34(9):1837-1846. PubMed ID: 37478497
[TBL] [Abstract][Full Text] [Related]
2. Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.
Kellie JF; Thomson AS; Chen S; Childs SL; Karlinsey MZ; Mai SH; White JR; Biddlecombe RA
J Pharm Sci; 2019 Apr; 108(4):1415-1422. PubMed ID: 30465782
[TBL] [Abstract][Full Text] [Related]
3. Intact mAb LC-MS for drug concentration from pre-clinical studies: bioanalytical method performance and in-life samples.
Kellie JF; Alelyunas YW; Albert J; Schneck NA; Chen Z; Sychterz CJ; Edwards I; Shion H; Wrona MD; Szapacs ME
Bioanalysis; 2020 Oct; 12(19):1389-1403. PubMed ID: 32975433
[No Abstract] [Full Text] [Related]
4. A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics.
Kellie JF; Kehler JR; Mencken TJ; Snell RJ; Hottenstein CS
Bioanalysis; 2016 Oct; 8(20):2103-14. PubMed ID: 27611496
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics.
Jenkins R; Duggan JX; Aubry AF; Zeng J; Lee JW; Cojocaru L; Dufield D; Garofolo F; Kaur S; Schultz GA; Xu K; Yang Z; Yu J; Zhang YJ; Vazvaei F
AAPS J; 2015 Jan; 17(1):1-16. PubMed ID: 25392238
[TBL] [Abstract][Full Text] [Related]
6. The flexibility of a generic LC-MS/MS method for the quantitative analysis of therapeutic proteins based on human immunoglobulin G and related constructs in animal studies.
Lanshoeft C; Wolf T; Walles M; Barteau S; Picard F; Kretz O; Cianférani S; Heudi O
J Pharm Biomed Anal; 2016 Nov; 131():214-222. PubMed ID: 27599352
[TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
[TBL] [Abstract][Full Text] [Related]
8. Multi-Attribute Method (MAM) Analytical Workflow for Biotherapeutic Protein Characterization from Process Development to QC.
Millán-Martín S; Jakes C; Carillo S; Bones J
Curr Protoc; 2023 Nov; 3(11):e927. PubMed ID: 37929772
[TBL] [Abstract][Full Text] [Related]
9. LC-MS bioanalysis of intact proteins and peptides.
Kang L; Weng N; Jian W
Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
[TBL] [Abstract][Full Text] [Related]
10. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry.
Doneanu CE; Xenopoulos A; Fadgen K; Murphy J; Skilton SJ; Prentice H; Stapels M; Chen W
MAbs; 2012; 4(1):24-44. PubMed ID: 22327428
[TBL] [Abstract][Full Text] [Related]
11. Performance metrics for evaluating system suitability in liquid chromatography--Mass spectrometry peptide mass mapping of protein therapeutics and monoclonal antibodies.
Zhou M; Gucinski AC; Boyne MT
MAbs; 2015; 7(6):1104-17. PubMed ID: 26218711
[TBL] [Abstract][Full Text] [Related]
12. Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches.
Camperi J; Goyon A; Guillarme D; Zhang K; Stella C
Analyst; 2021 Feb; 146(3):747-769. PubMed ID: 33410843
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery.
Sleczka BG; D'Arienzo CJ; Tymiak AA; Olah TV
Bioanalysis; 2012 Jan; 4(1):29-40. PubMed ID: 22191592
[TBL] [Abstract][Full Text] [Related]
14. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
Wu ST; Ouyang Z; Olah TV; Jemal M
Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
[TBL] [Abstract][Full Text] [Related]
15. Eliminating Preparation of Multisample External Calibration Curves and Dilution of Study Samples Using the Multiple Isotopologue Reaction Monitoring (MIRM) Technique in Quantitative LC-MS/MS Bioanalysis.
Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2019 Jul; 91(13):8652-8659. PubMed ID: 31180205
[TBL] [Abstract][Full Text] [Related]
16. LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.
van den Broek I; van Dongen WD
Bioanalysis; 2015; 7(15):1943-58. PubMed ID: 26295992
[TBL] [Abstract][Full Text] [Related]
17. In-Sample Calibration Curve Using Multiple Isotopologue Reaction Monitoring of a Stable Isotopically Labeled Analyte for Instant LC-MS/MS Bioanalysis and Quantitative Proteomics.
Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2019 Feb; 91(3):2536-2543. PubMed ID: 30615432
[TBL] [Abstract][Full Text] [Related]
18. Isobaric Tandem Mass Tag Multiplexed Post-Translational Modification Quantitation of Biopharmaceuticals by Targeted High-Resolution Mass Spectrometry.
Mao Y; Kleinberg A; Li N
Anal Chem; 2020 Jul; 92(14):9682-9690. PubMed ID: 32559367
[TBL] [Abstract][Full Text] [Related]
19. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
Ewles M; Goodwin L
Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
[TBL] [Abstract][Full Text] [Related]
20. Bioanalytical method validation considerations for LC-MS/MS assays of therapeutic proteins.
Duggan JX; Vazvaei F; Jenkins R
Bioanalysis; 2015; 7(11):1389-95. PubMed ID: 26110712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
